OQROGet OQRO Pro
Insider trade

Boston Scientific (BSX)Director sold ~$447K

Edward J Ludwig, Director at Boston Scientific, sold ~$447K of Boston Scientific shares.

~$447K
Approx. value · 4,877 sh @ $91.63
39K
Holds after · shares reported
Traded
Nov 21, 2024
Filed
Nov 22, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 1, 2024InsiderOfficer sold ~$586K of BSX shares in the open market
  2. Oct 7, 2024Insider · 2 peopleInsiders: 3 sales (~$25.0M)
  3. Nov 1, 2024InsiderOfficer sold ~$589K of BSX shares in the open market
  4. Nov 5, 2024Insider · 1 personInsiders: 2 sales (~$13.8M)
  5. Nov 8, 2024InsiderOfficer sold ~$2.68M of BSX shares in the open market
  6. Nov 21, 2024 · this disclosureInsiderDirector sold ~$447K of BSX shares in the open market

What came next

  1. Nov 25, 2024InsiderOfficer sold ~$1.25M of BSX shares in the open market
  2. Nov 27, 2024InsiderOfficer sold ~$121K of BSX shares in the open market
  3. Dec 2, 2024InsiderOfficer sold ~$634K of BSX shares in the open market
  4. Dec 3, 2024InsiderOfficer purchased ~$4.5K of BSX shares in the open market
  5. Dec 10, 2024InsiderOfficer sold ~$1.8K of BSX shares in the open market
  6. Dec 20, 2024FDARecall: AXIOS Stent and Delivery System 10mmx10mm UPN: M00553740
  7. Dec 20, 2024FDARecall: HOT AXIOS Stent and Electrocautery- Enhanced Delivery System 10mmx10mm UPN: M00553540
  8. Dec 20, 2024FDARecall: HOT AXIOS Stent and Electrocautery- Enhanced Delivery System 20mmx10mm UPN: M00553560
  9. Dec 20, 2024FDARecall: HOT AXIOS Stent and Electrocautery- Enhanced Delivery System 15mmx10mm UPN: M00553550
  10. Dec 20, 2024FDARecall: AXIOS Stent and Electrocautery- Enhanced Delivery System 15mmx10mm UPN: M00553650
  11. Dec 20, 2024FDARecall: AXIOS Stent and Electrocautery- Enhanced Delivery System 15mmx15mm UPN: M00553670
  12. Dec 20, 2024FDARecall: AXIOS Stent and Electrocautery- Enhanced Delivery System 6mmx8mm UPN: M00553680
  13. Dec 20, 2024FDARecall: AXIOS Stent and Electrocautery- Enhanced Delivery System 10mmx10mm UPN: M00553640
  14. Dec 20, 2024FDARecall: AXIOS Stent and Electrocautery- Enhanced Delivery System 8mmx8mm UPN: M00553690
  15. Dec 20, 2024FDARecall: HOT AXIOS Stent and Electrocautery- Enhanced Delivery System 8mmx8mm UPN: M00553530
  16. Dec 20, 2024FDARecall: HOT AXIOS Stent and Electrocautery- Enhanced Delivery System 15mmx15mm UPN: M00553570
  17. Dec 20, 2024FDARecall: HOT AXIOS Stent and Electrocautery- Enhanced Delivery System 6mmx8mm UPN: M00553520
  18. Jan 2, 2025InsiderOfficer sold ~$371K of BSX shares in the open market
  19. Jan 3, 2025Insider · 3 peopleInsiders: 3 sales (~$1.7M)
  20. Feb 3, 2025Insider · 1 personInsiders: 2 sales (~$1.8M)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Boston Scientific

For Boston Scientific, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 9 Congress trade reports, 64 fund holdings reports (13F) and 8 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BSX page.

Other recent filings by Edward J Ludwig, Director

The full history of Edward J Ludwig, Director is on the profile page.

How this filing works

Other disclosures at Boston Scientific

Everything OQRO holds on this company is on its BSX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data